Nanomaterial-assisted epigenetic engineering of the blood–brain barrier: A dual strategy for drug delivery and permeability control
Recent advances at the interface of nanotechnology, epigenetics, and neurobiology have created new opportunities to address the blood–brain barrier (BBB), a major challenge in the treatment of central nervous system disorders. Two complementary strategies are gaining increasing attention: the epigenetic modulation of B...